Related Experiment Video
Updated: Apr 25, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
2.8K
Vasopressor weaning in patients with septic shock
Daniel L Arellano1, Sandra K Hanneman2
1Division of Critical Care, Department of Medicine, Houston Methodist Hospital, 6550 Fannin Street, Suite SM1001, Houston, TX 77030, USA; Department of Family Health, School of Nursing, University of Texas Health Science Center at Houston, Room# 796, 6901 Bertner Avenue, Houston, TX 77030, USA.
Critical Care Nursing Clinics of North America
|August 30, 2014
Summary
This article proposes optimal strategies for weaning vasopressors in septic shock patients. It covers sepsis pathophysiology, treatment, and new research directions for improved patient outcomes.
Area of Science:
- Critical Care Medicine
- Pharmacology
Background:
- Sepsis and septic shock are life-threatening conditions requiring intensive management.
- Vasopressors are critical for maintaining hemodynamic stability but require careful titration and weaning.
Purpose of the Study:
- To propose optimal weaning strategies for vasopressors in patients with septic shock.
- To provide a comprehensive overview of current knowledge and future directions in septic shock management.
Main Methods:
- Review of existing literature on sepsis pathophysiology and vasopressor use.
- Analysis of current treatment guidelines and autoregulation principles.
- Discussion of monitoring and alarm systems in intensive care units.
Main Results:
- Identification of key factors influencing vasopressor weaning decisions.
- Recommendations for a structured approach to vasopressor de-escalation.
- Highlighting the importance of individualized patient care.
Conclusions:
- Optimizing vasopressor weaning can improve patient outcomes and reduce complications.
- Further research is needed to refine weaning protocols and explore novel therapeutic approaches.
Related Concept Videos
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
455
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
455
01:30Heart Failure V: Medical Management
617
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
617
01:17Aortic Regurgitation IV: Nursing Management
443
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
443
01:22Heart Failure Drugs: β-Blockers
2.5K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.5K
01:26Heart Failure Drugs: Inotropic Agents
1.9K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.9K
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K